The mAb-hERG1 (MCK Therapeutics; Florence, Italy; patent number IT1367861) was produced by secretion from an hybridoma cell line (named A7) obtained from mice cell fusion and able to secrete the monoclonal antibody (Guasti et al., 2008 (link); Lastraioli et al., 2020 (link); Lottini et al., 2021 (link)). Hybridoma cells are routinely maintained in DMEM (Euroclone) supplemented with Glutamine 10 mM and 5% Fetal Clone serum (Euroclone). Supernatant is harvested and purified by affinity chromatography using AKTA Pure (Cytiva) mounted with Protein A columns (Cytiva).
Free full text: Click here